Rankings
▼
Calendar
ARGX FY 2024 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$46B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2.2B
+78.6% YoY
Gross Profit
$2.0B
89.6% margin
Operating Income
-$22M
-1.0% margin
Net Income
$833M
38.0% margin
EPS (Diluted)
$12.78
Cash Flow
Operating Cash Flow
-$83M
Free Cash Flow
-$151M
Stock-Based Comp.
$235M
Balance Sheet
Total Assets
$6.2B
Total Liabilities
$704M
Stockholders' Equity
$5.5B
Cash & Equivalents
$1.5B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.2B
$1.2B
+78.6%
Gross Profit
$2.0B
$1.1B
+77.1%
Operating Income
-$22M
-$425M
+94.9%
Net Income
$833M
-$295M
+382.3%
← Q4 2023
All Quarters
Q1 2024 →